Rajszwe, Poland

Jacek Pstrzoch

USPTO Granted Patents = 2 



Average Co-Inventor Count = 21.0

ph-index = 1


Location History:

  • Warsaw, PL (2013)
  • Rajszwe, PL (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Diabetes Treatment by Jacek Pstrzoch

Introduction

Jacek Pstrzoch is a notable inventor based in Rajszwe, Poland, recognized for his contributions to the field of diabetes treatment. He holds two patents that focus on insulin analogues and their therapeutic applications. His work aims to improve the management of diabetes through innovative pharmaceutical solutions.

Latest Patents

Jacek Pstrzoch's latest patents include an insulin analogue or its pharmaceutically acceptable salt, along with a pharmaceutical composition designed for prolonged therapeutic effect. These inventions address the need for stable insulin analogues that provide a flat, peakless glucose concentration over time. This approach aims to minimize fluctuations in glucose levels, thereby reducing the risk of complications such as night hypoglycaemias. The insulin analogues developed by Pstrzoch are designed to mimic the natural secretion of insulin by a healthy pancreas, offering a more effective treatment option for diabetes patients.

Career Highlights

Throughout his career, Jacek Pstrzoch has worked with esteemed institutions such as the Institute of Biotechnology and Antibiotics. His research has significantly contributed to the understanding and treatment of diabetes, particularly through the development of new biosynthetic analogues of human insulin with prolonged therapeutic activity.

Collaborations

Jacek Pstrzoch has collaborated with notable colleagues, including Piotr Borowicz and Justyna Bernat. These partnerships have enhanced the research and development of innovative solutions in the field of diabetes treatment.

Conclusion

Jacek Pstrzoch's work in developing insulin analogues represents a significant advancement in diabetes management. His innovative approach aims to improve patient outcomes and reduce the adverse effects associated with traditional insulin therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…